Search
for
Sort by
Research 121–150 of 1000+
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Table of Contents
- Comparative Effects of Ustekinumab and Vedolizumab on Alopecia in Ulcerative Colitis: A Systematic Review and Meta-Analysis
- Drug eruptions in dermatology
- The Biology of Hair Follicles
- The Rotterdam Study: 2018 update on objectives, design and main results
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Surface Lipids as Multifunctional Mediators of Skin Responses to Environmental Stimuli
- The Facial Adipose Tissue: A Revision
- Telogen effluvium
- Drug-induced acne
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA)
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines
- An Update on Drug-Induced Pigmentation
- A review on laser and light-based therapies for alopecia areata
- Mesococktails and mesoproducts in aesthetic dermatology
- CUTANEOUS T-CELL LYMPHOMA
- Symptom management in inflammatory bowel disease
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Clinical Patterns of Hair Loss in Men
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Role of the Wnt signaling pathway in keratoacanthoma
- Dermatologic Adverse Events from Cancer Treatments
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype